Welcome Guest | Register / Login

Bladder Cancer Market Research Reports

Sort By
Title Published Price
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016
By Delve Insight
DelveInsight's, " Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Non Muscle Invasive Bladder Cancer...
Nov 2016 $ 1250
Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016
By Delve Insight
DelveInsight's, " Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Non Muscle Invasive Bladder Cancer (NMIBC). The DelveInsight'sR...
Nov 2016 $ 1250
Gallbladder Cancer-Pipeline Insights, 2016
By Delve Insight
DelveInsight's, " Gallbladder Cancer-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Gallbladder Cancer. The DelveInsight'sReport covers the product profiles in various sta...
Nov 2016 $ 1250
Global Bladder Cancer Partnering 2010 to 2016
By Current Partnering
"Delivery of this report will take 1-3 days after purchase." The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the...
Nov 2016 $ 1495
Bladder Cancer Treatment Drugs Industry Forecasts - China Focus
By AMID
This study focuses on China's Bladder Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in Ch...
Mar 2016 $ 1000
Bladder Cancer - Executive Market Summary 2013
By Timely Data resources
TheBladder Cancer Executive Market Summary 2013 provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview ...
May 2013 $ 995
The 2013-2018 Outlook for Bladder Cancer Therapeutics in Greater China
By ICON Group International, Inc.
This econometric study covers the latent demand outlook for bladder cancer therapeutics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing,...
Jan 2013 $ 495
Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012
By Global Markets Direct
Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2012'', provides an overview of the Muscle Invasive...
Jul 2012 $ 500
Gallbladder Cancer – Pipeline Review, H1 2012
By Global Markets Direct
Gallbladder Cancer – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Gallbladder Cancer - Pipeline Review, H1 2012', provides an overview of the Gallbladder Cancer therapeutic pipeline. This report pr...
Apr 2012 $ 500
Bladder Cancer – Pipeline Review, H1 2012
By Global Markets Direct
Bladder Cancer – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Bladder Cancer - Pipeline Review, H1 2012', provides an overview of the Bladder Cancer therapeutic pipeline. This report provides infor...
Feb 2012 $ 500
Bladder Cancer - Pipeline Review, H2 2011
By Global Markets Direct
Bladder Cancer - Pipeline Review, H2 2011SummaryGlobal Markets Direct’s, 'Bladder Cancer - Pipeline Review, H2 2011', provides an overview of the Bladder Cancer therapeutic pipeline. This report provides information ...
Sep 2011 $ 500
Bladder Cancer - Pipeline Review, Q1 2011
By Global Markets Direct
Report SummaryGlobal Markets Direct’s, 'Bladder Cancer - Pipeline Review, Q1 2011', provides an overview of the Bladder Cancer therapeutic pipeline. This report provides information on the therapeutic developm...
Feb 2011 $ 500
The 2011-2016 World Outlook for Bladder Cancer Therapeutics
By ICON Group International, Inc.
This econometric study covers the world outlook for bladder cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q...
Jan 2011 $ 795
The 2011-2016 Outlook for Bladder Cancer Therapeutics in Greater China
By ICON Group International, Inc.
This econometric study covers the latent demand outlook for bladder cancer therapeutics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (B...
Jan 2011 $ 495